Drug intelligence / Profile preview

RXM-5201 (68Ga)

Development stage
Unknown
Lead developer
3B Pharmaceuticals
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
Administration
Intravenous
01

Overview

RXM-5201 (68Ga) is a Gallium-68 labeled radiopharmaceutical imaging agent developed by 3B Pharmaceuticals. It is designed to target Fibroblast Activation Protein (FAP), a cell surface protease that is highly expressed on cancer-associated fibroblasts within the stroma of various solid tumors. The agent is intended for use in Positron Emission Tomography (PET) or Single-Photon Emission Computed Tomography (SPECT) imaging to detect and characterize FAP-expressing tumors. By visualizing FAP expression, RXM-5201 may assist in patient selection for FAP-targeted therapies and monitoring treatment response. It is currently in early-stage clinical development, specifically in a first-in-human Phase 0 study.

Other names
[68Ga]RXM-520168Ga-RXM-5201
02

Targets

FAP (Fibroblast activation protein alpha)

Beyond the preview

Go deeper on RXM-5201 (68Ga).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RXM-5201 (68Ga).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call